Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 20, 2022 ERNAW M 20,163 · · 60,487 Direct -25.00% Disposed (price as of 2026-10-02)
Sept. 20, 2022 ERNAW M 20,163 · · 20,163 Direct · Acquired (price as of 2026-10-02)
March 11, 2022 ERNAW A 142,100 · · 142,100 Direct · Acquired (price as of 2026-10-02)
March 11, 2022 ERNAW A 142,100 · · 142,100 Direct · Acquired (price as of 2026-10-02)
Sept. 20, 2021 ERNAW A 80,650 · · 80,650 Direct · Acquired (price as of 2026-10-02)
Sept. 20, 2021 ERNAW A 161,300 · · 161,300 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 20, 2022 ERNAW Restricted Stock Units Common Stock (20,163) · · 20,163 Disposed
March 11, 2022 ERNAW Stock Option (Right to buy) Common Stock (142,100) $1.93 March 11, 2032 142,100 Acquired
March 11, 2022 ERNAW Stock Option (Right to buy) Common Stock (142,100) $1.93 March 11, 2032 142,100 Acquired
Sept. 20, 2021 ERNAW Restricted Stock Unit Common Stock (80,650) · Sept. 20, 2031 80,650 Acquired
Sept. 20, 2021 ERNAW Stock Option Common Stock (161,300) $9.96 Sept. 20, 2031 161,300 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
July 8, 2025 CRDF Employee Stock Option (right to buy)→ Common Stock (600,000) 600,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ERNAW

Former Chief Medical Officer(9)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $447,200 · · · · · · $927,472
2021 $127,045 · · · $48,277 · · $2,464,727
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $279,370 · · $1,920,275 $74,160 · · $2,273,805

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.